ATE297209T1 - Podophyllotoxin-zusammensetzungen - Google Patents

Podophyllotoxin-zusammensetzungen

Info

Publication number
ATE297209T1
ATE297209T1 AT01900598T AT01900598T ATE297209T1 AT E297209 T1 ATE297209 T1 AT E297209T1 AT 01900598 T AT01900598 T AT 01900598T AT 01900598 T AT01900598 T AT 01900598T AT E297209 T1 ATE297209 T1 AT E297209T1
Authority
AT
Austria
Prior art keywords
podophyllotoxin
compositions
discloses
present
podophylootoxin
Prior art date
Application number
AT01900598T
Other languages
English (en)
Inventor
Olivier Lutz
Evgueni Klinski
Shengmin Li
Valery Alakhov
Original Assignee
Supratek Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supratek Pharma Inc filed Critical Supratek Pharma Inc
Application granted granted Critical
Publication of ATE297209T1 publication Critical patent/ATE297209T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
AT01900598T 2000-01-20 2001-01-11 Podophyllotoxin-zusammensetzungen ATE297209T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48829800A 2000-01-20 2000-01-20
PCT/IB2001/000087 WO2001052826A2 (en) 2000-01-20 2001-01-11 Novel podophyllotoxin compositions

Publications (1)

Publication Number Publication Date
ATE297209T1 true ATE297209T1 (de) 2005-06-15

Family

ID=23939161

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01900598T ATE297209T1 (de) 2000-01-20 2001-01-11 Podophyllotoxin-zusammensetzungen

Country Status (8)

Country Link
US (1) US20060148728A1 (de)
EP (1) EP1251858B1 (de)
JP (1) JP2003520227A (de)
AT (1) ATE297209T1 (de)
AU (1) AU2001225432A1 (de)
CA (1) CA2397871A1 (de)
DE (1) DE60111352T2 (de)
WO (1) WO2001052826A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102168D0 (sv) 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
CA2470524A1 (en) 2001-12-21 2003-07-24 David S. Soane Use of oligomers and polymers for drug solublization, stabilization, and delivery
US7846422B2 (en) * 2003-08-04 2010-12-07 Kao Corporation Method for prevention or treatment of periodontal diseases and composition for an oral cavity
JP2008506780A (ja) * 2004-07-19 2008-03-06 セレーター ファーマスーティカルズ、インク． 活性剤放出のための粒子状構築物
WO2009083972A2 (en) * 2008-01-03 2009-07-09 Do-Coop Technologies Ltd. Compositions and methods for enhancing the activity of podophyllotoxin
BR112012033295A2 (pt) 2010-07-02 2016-10-11 Angiochem Inc polipeptídeos curtos e contendo d-aminoácido para conjugados terapêuticos e seu uso
CN102423302A (zh) * 2011-11-21 2012-04-25 中国药科大学 载鬼臼苦素纳米胶束制剂和冻干制剂及其制备方法
CN102526226A (zh) * 2011-12-31 2012-07-04 沈阳药科大学 中药组方在解除肝肾毒性方面的应用
CN103304574A (zh) * 2013-03-29 2013-09-18 西南交通大学 抗癌用4’-去甲峨参内酯及其制备方法
CN104415194A (zh) * 2013-09-11 2015-03-18 罗兴富 一种治疗颈***核病的新型药物及其制备方法
US9592188B2 (en) 2014-05-22 2017-03-14 Yansong Liu Method of treating or reducing the severity of dermatological conditions
CN104435117A (zh) * 2014-12-12 2015-03-25 王正琦 一种治疗***瘤的中药组合物
CN104958547A (zh) * 2015-06-26 2015-10-07 四川金堂海纳生物医药技术研究所 一种可治疗***结核的内服消结汤及制备方法
RU2674029C1 (ru) * 2017-08-24 2018-12-04 Илья Александрович Марков Ректальные свечи и способ их приготовления (варианты)
WO2019051733A1 (zh) * 2017-09-14 2019-03-21 顾崧 一种依托泊苷胶束的制备方法
CN108552095B (zh) * 2018-03-15 2020-08-21 浙江省淡水水产研究所 一种育苗安全用水的处理方法
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
CN113750255B (zh) * 2021-09-30 2023-10-31 大连民族大学 环境响应型透明质酸-鬼臼毒素前药胶束及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
CA2166722A1 (en) * 1994-05-06 1995-11-16 Manoj L. Maniar Use of vitamin e tocopheryl derivatives in ophthalmic compositions
US5534499A (en) * 1994-05-19 1996-07-09 The University Of British Columbia Lipophilic drug derivatives for use in liposomes
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
AU730216B2 (en) * 1996-09-01 2001-03-01 Pharmos Corporation Solid coprecipitates for enhanced bioavailability of lipophilic substances
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US5798333A (en) * 1996-09-17 1998-08-25 Sherman; Bernard C. Water-soluble concentrates containing cyclosporins
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes

Also Published As

Publication number Publication date
WO2001052826A2 (en) 2001-07-26
JP2003520227A (ja) 2003-07-02
WO2001052826A3 (en) 2002-03-14
AU2001225432A1 (en) 2001-07-31
CA2397871A1 (en) 2001-07-26
US20060148728A1 (en) 2006-07-06
EP1251858A2 (de) 2002-10-30
DE60111352D1 (de) 2005-07-14
EP1251858B1 (de) 2005-06-08
DE60111352T2 (de) 2006-05-04

Similar Documents

Publication Publication Date Title
ATE297209T1 (de) Podophyllotoxin-zusammensetzungen
EE200100485A (et) Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena
BRPI0113162B8 (pt) compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos
EP1248612A4 (de) Neue substanzen und verbindungen als protease-inhibitoren
DK1157037T3 (da) GCSF-konjugater
MXPA03005464A (es) Agentes antivirales.
MA26880A1 (fr) Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation.
DZ3402A1 (fr) Cyclopentanoindoles, compositions contenant ces composes et methodes de traitement
DK1087960T3 (da) Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
ES2194452T3 (es) Composiciones antitranspirantes que contienen 1,2-hexanodiol.
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
CO5590918A2 (es) Formulaciones
PA8495101A1 (es) Derivados de 13-metileritromicina
GT200000001A (es) Derivados de eter propargilico novedosos.
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
DE60114640D1 (en) Antithrombosemittel
ATE218560T1 (de) Wasserlösliche ähnliche verbindungen und medicament-vorstufe von paclitaxel
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
SE9803107D0 (sv) Novel Compunds
IT1302289B1 (it) Composizioni farmaceutiche ad attivita' antineoplastica
ATE307102T1 (de) 3,3-dimethylcyclohexan-derivate
WO2002044403A3 (en) Markers for testing analogs of vitamin d and therapeutical uses
MXPA03003466A (es) Derivados de piranosido.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties